Evidence map›Paper›PMID 17261658›Full record

ArticleCirculation2007

Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells.

Amar M Singh, Feng-Qian Li, Takashi Hamazaki, Hideko Kasahara, Ken-ichi Takemaru, Naohiro Terada

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Circulation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amar M SinghDepartment of Pathology, University of Florida College of Medicine, Box 100275, Gainesville, FL 32610, USA.
Feng-Qian Li
Takashi Hamazaki
Hideko Kasahara
Ken-ichi Takemaru
Naohiro Terada
Stony Brook School · US

Funding

Nkx2.5-dependent pathways in postnatal cardiomyocytesR01HL081577 · NHLBI · UNIVERSITY OF FLORIDA · PI KASAHARA, HIDEKO · 2005 to 2009
$1.9M
Role of Beta-Catenin Antagonist Chibby in AdipogenesisR01DK073191 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI TAKEMARU, KEN-ICHI · 2006 to 2010
$1.5M
NHLBI NIH HHS R01 HL081577NIDDK NIH HHS R01 DK073191
6 · The paper itself

Abstract

backgroundEmbryonic stem cell (ESC)-derived cardiomyocytes are anticipated to serve as a useful source for future cell-based cardiovascular disease therapies. Research emphasis is currently focused on determining methods to direct the differentiation of ESCs to a large population of cardiomyocytes with high purity. To this aim, understanding the molecular mechanisms that control ESC-to-cardiomyocyte differentiation should play a critical role in the development of this methodology. The Wnt/beta-catenin signaling pathway has been implicated in both embryonic cardiac development and in vitro ESC differentiation into cardiomyocytes. Chibby is a recently identified nuclear protein that directly binds to beta-catenin and antagonizes its transcriptional activity. METHODS AND

resultsChibby was ubiquitously expressed in early stages of ESC differentiation but upregulated during cardiomyocyte specification. Of interest, the Chibby gene promoter has multiple binding sites for the cardiac-specific homeodomain protein Nkx2.5, and its promoter activity was indeed positively regulated by Nkx2.5. Furthermore, overexpression of Chibby increased cardiac differentiation of ESCs, whereas loss of Chibby by RNAi impaired cardiomyocyte differentiation.

conclusionsThese data illustrate the regulation and function of Chibby in facilitating cardiomyocyte differentiation from ESCs. By revealing molecular mechanisms that control ESC-to-cardiomyocyte differentiation, this study will allow for the future development of technologies to improve cardiomyocyte differentiation from ESCs.

Indexed as

Animalsbeta CateninCarrier ProteinsCell DifferentiationCell LineCell Line, TransformedDown-RegulationEmbryonic Stem CellsHumansMiceMyocytes, CardiacNuclear ProteinsSignal TransductionWnt Proteinsbeta CateninCarrier ProteinsCBY1 protein, humanChibby protein, mouseNuclear ProteinsWnt Proteins

Identifiers

PMID17261658
PMCPMC2565513
OpenAlexW1992313721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.